Biopharma

European sales and use of antimicrobials for veterinary...

European sales and use of antimicrobials for veterinary medicine: Annual surveil...

How discoverable, comparable and explorable is your data?

Accelerate biomarker research with high-quality, expert-curated data to drive pr...

Lilly links lepodisiran to durably lower lipoprotein in...

Eli Lilly has linked lepodisiran to sustained reductions in a cardiovascular dis...

Vertex abandons islet cell-device combo after failing t...

Vertex is ending work on one of its two islet cell treatments after the diabetes...

Down to their heart cells, women and men have cardiovas...

Did you know men and women's heart cells prefer different kinds of fuel? Gender ...

Opinion: Medical schools are eliminating the use of cad...

“What will be lost when medical students are no longer made to uncomfortably fac...

Opinion: Uber for nursing is here — and it’s not good f...

“I just feel like I am on an island by myself a lot”: How gig working leaves nur...

STAT+: State and local health departments grapple with ...

Food programs, outbreak monitoring, mental health aid: state and local health of...

FDA Approves Expanded Use of Soliris (eculizumab) for P...

New York, March 10, 2025 – The Muscular Dystrophy Association (MDA) welcomes the...

Monthly News Roundup - March 2025

FDA Approves Tremfya for Adults Patients with Active Crohn’s Disease In March, J...

Preclinical study: after heart attack, a boost in anti-...

A scientific technique that rapidly increases the body's production of anti-infl...

Bayer and Puhe BioPharma enter into global license agre...

Bayer and Suzhou Puhe BioPharma Co., Ltd., a clinical-stage biotechnology compan...

Enzyme engineering opens door to novel therapies for Pa...

Scientists have long struggled to target proteins that lack defined structure an...

STAT+: FDA’s ‘key man’ Peter Marks is out. Biotech inve...

Peter Marks’ ouster comes at a time when the sector is already suffering through...

FDA Approves Qfitlia (fitusiran) to Treat Hemophilia A ...

Paris, March 28, 2025. The US Food and Drug Administration (FDA) has approved Qf...

Opinion: STAT+: Peter Marks’ ouster is an ominous sign ...

Welcome to Lab Dish, a new First Opinion column on regenerative medicine from Pa...

STAT+: Ouster of FDA’s Peter Marks alarms a biopharma i...

Will Peter Marks' ouster from the FDA change how pharma industry engages with th...

Peter Marks, FDA’s top vaccine official, resigns

In his resignation letter, Marks cited disagreement with HHS Secretary Robert F....

Top US vaccine official resigns over Kennedy’s ‘misinfo...

Peter Marks says ‘truth and transparency are not desired’ by health secretary as...

FDA Approves Bomyntra (denosumab-bnht), a Biosimilar to...

LAKE ZURICH, Ill., March 27, 2025 -- Fresenius announced that the Biologics Lice...

FDA Approves Conexxence (denosumab-bnht), a Biosimilar ...

LAKE ZURICH, Ill., March 27, 2025 -- Fresenius announced that the Biologics Lice...

FDA Approves Imfinzi (durvalumab) for Muscle Invasive ...

On March 28, 2025, the Food and Drug Administration approved durvalumab (Imfinzi...

Merck’s Investigational Subcutaneous Pembrolizumab With...

RAHWAY, N.J.--(BUSINESS WIRE) March 27, 2025 -- Merck (NYSE: MRK), known as MSD...

Peter Marks, FDA’s top vaccine regulator, forced out

Top FDA official Peter Marks was forced to resign as the director of the Center ...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.